Interpace Biosciences
OTC: IDXGParsippany, US · Delaware corporation · 1 known investors
Healthtech
Founders & leadership
CM
Christopher McCarthyChief Financial Officer
TW
Thomas W. BurnellExecutive Officer, Director
JE
James EarlyCFO
JE
Jack E StoverPresident and CEO
SJ
Stephen J. SullivanDirector
VA
Vijay AggarwalDirector
JK
Joseph KeeganDirector
FR
Fortunato Ron RoccaDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$47MraisedOct 2024 · 2 investors · Other Health CareRule 506(b)
▶$47MraisedOct 2024 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen J. SullivanDirector
- Vijay AggarwalDirector
- Joseph KeeganDirector
- Fortunato Ron RoccaDirector
- Christopher McCarthyExecutive Officer
- Thomas W. BurnellExecutive Officer, Director
- Offering amount
- $47M
- Amount sold
- $47M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$47MraisedJan 2020 · 2 investors · Other Health CareRule 506(b)
▶$47MraisedJan 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Felice Schnoll-SussmanDirector
- Gregory RichardExecutive Officer
- Eric LevDirector
- Laurence R. McCarthyDirector
- Robert GormanDirector
- Thomas FreeburgExecutive Officer
- Fortunato Ron RoccaDirector
- Jack E. StoverExecutive Officer, Director
- James EarlyExecutive Officer
- Joseph KeeganDirector
- Stephen J. SullivanDirector
- Edward ChanDirector
- Offering amount
- $47M
- Amount sold
- $47M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedJul 2019 · 1 investors · Other Health CareRule 506(b)
▶$14MraisedJul 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jack E. StoverExecutive Officer, Director
- James EarlyExecutive Officer
- Joseph KeeganDirector
- Stephen J. SullivanDirector
- Thomas FreeburgExecutive Officer
- Felice Schnoll-SussmanDirector
- Gregory RichardExecutive Officer
- Eric LevDirector
- Offering amount
- $27M
- Amount sold
- $14M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2017 · 4 investors · Other Health CareRule 506(b)
▶$5MraisedOct 2017 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregory RichardExecutive Officer
- Felice Schnoll-SussmanDirector
- James EarlyExecutive Officer
- Jack E. StoverExecutive Officer, Director
- Stephen J. SullivanDirector
- Joseph KeeganDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $225K
- Placement agents
- Maxim Group LLC
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$111.2KraisedJan 2017 · 6 investors · Other Health CareRule 506(b)
▶$111.2KraisedJan 2017 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James EarlyExecutive Officer
- Jack E StoverExecutive Officer, Director
- Stephen J SullivanDirector
- Joseph KeeganDirector
- Offering amount
- $4.1M
- Amount sold
- $111.2K
- Sales commissions
- $329.7K
- Proceeds to insiders
- $111K
- Placement agents
- Maxim Group LLC
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.